Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1bu5 | RBF | Flavodoxin |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1bu5 | RBF | Flavodoxin | / | 1.000 | |
3f6r | FMN | Flavodoxin | / | 0.600 | |
1xyy | FMN | Flavodoxin | / | 0.548 | |
1c7f | FMN | Flavodoxin | / | 0.537 | |
1akw | FMN | Flavodoxin | / | 0.520 | |
1akr | FMN | Flavodoxin | / | 0.508 | |
5fx2 | FMN | Flavodoxin | / | 0.506 | |
4fx2 | FMN | Flavodoxin | / | 0.499 | |
5tgz | FMN | Cannabinoid receptor 1 | / | 0.499 | |
1azl | FMN | Flavodoxin | / | 0.480 | |
4y7c | FMN | NADPH--cytochrome P450 reductase | / | 0.478 | |
1fx1 | FMN | Flavodoxin | / | 0.473 | |
1j9g | FMN | Flavodoxin | / | 0.472 | |
4eph | 0RK | Carnitine O-palmitoyltransferase 2, mitochondrial | 2.3.1.21 | 0.472 | |
5xra | FMN | Cannabinoid receptor 1 | / | 0.466 | |
1j9z | FMN | NADPH--cytochrome P450 reductase | / | 0.465 | |
2fx2 | FMN | Flavodoxin | / | 0.464 | |
1ykg | FMN | Sulfite reductase [NADPH] flavoprotein alpha-component | / | 0.458 | |
3n3a | FMN | Protein NrdI | / | 0.454 | |
3ojx | FMN | NADPH--cytochrome P450 reductase | / | 0.454 | |
1aku | FMN | Flavodoxin | / | 0.445 | |
4b4w | 9L9 | Bifunctional protein FolD | / | 0.445 |